⌘K
Loading ticker…
As of 2026-08-24, Protara Therapeutics, Inc. Common Stock (TARA) has a 3-month relative strength percentile of 19 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 41. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.2%, relative volume 0.61×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TARA is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -3.8% / -25.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TARA is held by 12 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $2M.
Held by 24 ETFs · $23M across latest filings · largest weight 0.16% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| new |
| VTHRVanguard Russell 3000 ETF | 0.00% | $15K | — |
| ITWO | 0.01% | $11K | — |
| URTY | 0.00% | $9K | — |
| UWM | 0.00% | $9K | — |
Showing 10 of 12 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TARA Jan avg: 20.96% median: 27.33% win: 75% σ: 19.49% n: 4 2022-04-12 → 2026-07-31 | TARA Feb avg: 13.20% median: -1.03% win: 50% σ: 45.68% n: 4 2022-04-12 → 2026-07-31 | TARA Mar avg: -6.89% median: -11.70% win: 25% σ: 14.19% n: 4 2022-04-12 → 2026-07-31 | TARA Apr avg: -13.02% median: -17.84% win: 40% σ: 13.73% n: 5 2022-04-12 → 2026-07-31 | TARA May avg: -10.41% median: -11.71% win: 0% σ: 3.15% n: 5 2022-04-12 → 2026-07-31 | TARA Jun avg: -14.15% median: -14.34% win: 0% σ: 9.33% n: 5 2022-04-12 → 2026-07-31 | TARA Jul avg: 4.51% median: 2.62% win: 100% σ: 3.03% n: 5 2022-04-12 → 2026-07-31 | TARA Aug avg: -2.53% median: -4.83% win: 50% σ: 13.77% n: 4 2022-04-12 → 2026-07-31 (current) | TARA Sep avg: -1.67% median: -11.35% win: 25% σ: 28.07% n: 4 2022-04-12 → 2026-07-31 | TARA Oct avg: 8.63% median: 11.40% win: 75% σ: 26.51% n: 4 2022-04-12 → 2026-07-31 | TARA Nov avg: 23.46% median: 18.18% win: 100% σ: 12.85% n: 4 2022-04-12 → 2026-07-31 | TARA Dec avg: 13.22% median: 2.62% win: 50% σ: 48.99% n: 4 2022-04-12 → 2026-07-31 |